Australian Consumer Services Stock News

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

AuMake Limited ( ASX:AUK ) shareholders are no doubt pleased to see that the share price has bounced 50% in the last...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Qantas Airways fair value estimate is AU$11.87 Qantas Airways...

Despite an already strong run, Gullewa Limited ( ASX:GUL ) shares have been powering on, with a gain of 29% in the last...

Key Insights Significantly high institutional ownership implies Ansell's stock price is sensitive to their trading...

As the Australian market navigates through fluctuating inflation data and potential interest rate decisions, investors are closely watching how these factors could influence various sectors on the ASX. In such an environment, dividend stocks can offer a reliable income stream, making them an appealing choice for those looking to capitalize on steady returns amidst broader market uncertainties.

As the Australian market navigates through fluctuating inflation data and potential interest rate adjustments, sectors such as IT are showing resilience with notable gains, while energy faces pressure from stabilizing oil prices. In this environment, growth companies with high insider ownership can be particularly appealing to investors seeking alignment between management and shareholder interests, especially when these firms demonstrate significant earnings growth.

As the Australian market navigates a period of uncertainty with mixed signals from inflation data and potential rate hikes, investors are keenly observing sectors like IT and materials which have shown resilience amidst fluctuating conditions. In this environment, identifying undervalued stocks can be particularly rewarding, as these equities may offer significant upside potential once the broader economic landscape stabilizes.

As the Australian market shows resilience with a cooler-than-expected inflation read, investors are closely watching potential moves by the Reserve Bank of Australia. In such a climate, penny stocks can offer intriguing opportunities for those willing to explore beyond established names. Despite being an older term, penny stocks—often smaller or newer companies—remain relevant as they can provide affordability and growth potential when backed by strong financials.

GQG Partners (ASX:GQG) is back in focus after Charles Falck officially stepped into the chief financial officer role on 1 January 2026, following the retirement of long serving CFO Melodie Zakaluk. See our latest analysis for GQG Partners. The leadership change comes as the share price has shown positive momentum in recent months, with a 12.15% 90 day share price return but a 1 year total shareholder return decline of 2.25%, suggesting shorter term optimism alongside a more mixed longer term...

In late December 2025 and early January 2026, Mesoblast reshaped its governance and balance sheet, appointing Philip Facchina as non-executive Chair, Lyn Cobley as Audit and Risk Committee Chair, refinancing debt with a new up to US$125 million facility from director and shareholder Dr Gregory George, and filing US$250 million and US$9.48 million shelf registrations. These moves collectively signal Mesoblast’s progression from development-stage biotech toward a revenue-focused commercial...

BlueScope Steel: recent share performance in focus Recent trading in BlueScope Steel (ASX:BSL) has drawn attention after a strong run over the past 3 months, leaving investors weighing how the current A$29.87 share price lines up with fundamentals. See our latest analysis for BlueScope Steel. That recent 24.1% 7 day share price return and 37.97% 90 day share price return sit alongside a 58.6% 1 year total shareholder return. Together, these figures suggest strong momentum and a shift in how...

In early January 2026, South32 drew investor attention as copper prices reached record highs on supply disruption headlines, lifting sentiment across global miners ahead of the company’s late-January quarterly update and February half-year results. This combination of tighter copper supply and upcoming results has sharpened focus on how South32’s portfolio exposure to copper could influence its medium-term earnings profile. We’ll now examine how record copper prices amid supply disruption...

CSL has recently faced increased scrutiny after cutting its fiscal 2026 revenue growth outlook, pausing the planned Seqirus spin-off in response to weaker U.S. influenza vaccination demand, and committing A$1.50 billion over five years to expand its U.S. plasma-derived therapies manufacturing capacity. These moves highlight how CSL is recalibrating between a less certain vaccines backdrop and long-term investment in plasma therapies, sharpening questions about the balance between near-term...

In a recent company-backed video, investment commentator Tylah Tully reviewed Hot Chili’s progress toward definitive feasibility and near-term production at its Costa Fuego copper-gold project in Chile. The collaboration-focused presentation underscored Costa Fuego’s positioning as a globally significant copper-gold asset with a unique development advantage, highlighting key milestones on the path to production readiness. We’ll examine how this push toward definitive feasibility at Costa...

In 2025–2026, Telix Pharmaceuticals became the focus of multiple securities class action lawsuits after disclosures of an SEC subpoena and an FDA Complete Response Letter concerning its prostate cancer diagnostics and therapeutics. The allegations center on whether Telix accurately described the progress of its pipeline and the robustness of its third-party manufacturing network, raising wider questions about disclosure practices in complex biotech supply chains. We’ll now examine how...

Regis Resources (ASX:RRL) has drawn fresh attention after reporting second quarter fiscal 2026 gold production of 96,600 ounces. This comes alongside a broader gold sector rally supported by safe-haven demand and interest rate expectations. See our latest analysis for Regis Resources. The latest production update and sector tailwinds have come alongside a 27.1% 3 month share price return and a very large 1 year total shareholder return. This suggests momentum in investor expectations around...

Lynas Rare Earths recently drew renewed investor attention as markets reacted to rare-earth price signals from China and continued to focus on previously flagged operational risks at its Kalgoorlie processing facility, which could affect output at its Malaysian plant. As one of the few major rare earth producers outside China, Lynas sits at the center of efforts to secure critical mineral supply chains for electric vehicles, electronics, green energy and defense applications. We’ll now...

Wondering if FireFly Metals at A$2.03 is starting to look priced for perfection, or if the market is still underestimating it? This article walks through the key numbers so you can judge the value story for yourself. The share price has seen a 123.1% return over the last year, alongside a 9.7% gain over the past 30 days and a 2.9% decline in the last week. This hints at both interest in the stock and some short term volatility in how risk is being priced. Recent attention around FireFly...

Why Julian Sutton’s promotion matters for 4DMedical shareholders The recent 18% jump in 4DMedical (ASX:4DX) followed the appointment of long-time board member and early investor Julian Sutton as Chief Financial Officer and Executive Director on January 2, 2026. This move comes as the company shifts focus toward commercial growth, with its CT:VQ lung imaging software already FDA cleared, deployed at leading U.S. academic medical centres, and supported by a global distribution agreement with...

Calix (ASX:CXL) has drawn fresh attention after securing a three year supply contract with a major US agricultural company. The contract is expected to contribute up to A$10 million in revenue each year. See our latest analysis for Calix. The contract news arrived after a sharp move in the share price, with a 30 day share price return of 122.61% and a 90 day share price return of 224.05%. However, the 3 year total shareholder return of a 72.94% decline shows that longer term holders have had...

James Hardie Industries (ASX:JHX) has drawn fresh attention after a multi month rally that brought the stock close to its 52 week highs, as investors focus on margin discipline and resilient North American construction demand. See our latest analysis for James Hardie Industries. At A$31.35, the stock has a 1 month share price return of 5.48%, even though the 90 day share price return is a 5.69% decline and the 1 year total shareholder return is a 37.43% loss. Recent momentum is improving off...